Asano K, Nakamura H, Lilly C M, Klagsbrun M, Drazen J M
Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts 02115, USA.
J Clin Invest. 1997 Mar 1;99(5):1057-63. doi: 10.1172/JCI119233.
The induction of prostaglandin G/H synthase (PGHS; prostaglandin endoperoxide synthase, cyclooxygenase) by proinflammatory cytokines accounts, at least in part, for the altered eicosanoid biosynthesis in inflammatory diseases. In secondary cultures of normal human bronchial epithelial cells (NHBECs), interferon-gamma (IFN-gamma, 10 ng/ml for 24 h) increased the amount of prostaglandin E2 (PGE2) released in response to stimulation with exogenous arachidonic acid (5 microM). The enhanced production of PGE2 reflected the upregulation of PGHS-2 as indicated by enhanced expression of PGHS-2 RNA and increased recovery of PGHS-2 protein in NHBECs. IFN-gamma did not alter the production of PGE2 in A549 cells (a human lung adenocarcinoma cell line) or 6-keto-PGF1alpha in human umbilical vein endothelial cells (HUVECs), although prostaglandin release and/or the expression of PGHS-2 RNA in these cell lines was upregulated by other proinflammatory cytokines. Induction of PGHS-2 RNA in IFN-gamma-treated NHBECs, which peaked at 24 h, suggested the presence of an intermediary substance regulating the expression of PGHS-2. When the binding between the epidermal growth factor (EGF) receptor and its ligands was disrupted by a neutralizing antibody (LA-1), IFN-gamma failed to upregulate the release of PGE2 and the expression of PGHS-2 RNA in NHBECs. Furthermore, IFN-gamma induced the expression of RNAs for a number of ligands at the EGF receptor TGF-alpha; heparin-binding EGF-like growth factor (HB-EGF); and amphiregulin in NHBECs, and when administered exogenously, these ligands increased PGE2 release from NHBECs. Heparin at the concentration that neutralized the function of amphiregulin, or antibodies against TGFalpha or HB-EGF also reduced the release of PGE2 from IFN-gamma-stimulated NHBECs. These data are consistent with the presence of an autocrine growth factor/EGF receptor loop regulating PGHS-2 expression and PGE2 synthesis in bronchial epithelial cells.
促炎细胞因子对前列腺素G/H合酶(PGHS;前列腺素内过氧化物合酶,环氧化酶)的诱导至少部分解释了炎症性疾病中类花生酸生物合成的改变。在正常人支气管上皮细胞(NHBECs)的传代培养中,干扰素-γ(IFN-γ,10 ng/ml,作用24小时)增加了对外源性花生四烯酸(5 μM)刺激产生的前列腺素E2(PGE2)释放量。PGE2产生的增加反映了PGHS-2的上调,这表现为NHBECs中PGHS-2 RNA表达增强以及PGHS-2蛋白回收增加。IFN-γ未改变A549细胞(一种人肺腺癌细胞系)中PGE2的产生或人脐静脉内皮细胞(HUVECs)中6-酮-PGF1α的产生,尽管这些细胞系中前列腺素释放和/或PGHS-2 RNA的表达可被其他促炎细胞因子上调。IFN-γ处理的NHBECs中PGHS-2 RNA的诱导在24小时达到峰值,提示存在调节PGHS-2表达的中间物质。当中和抗体(LA-1)破坏表皮生长因子(EGF)受体与其配体之间的结合时,IFN-γ无法上调NHBECs中PGE2的释放和PGHS-2 RNA的表达。此外,IFN-γ诱导NHBECs中EGF受体的多种配体RNA的表达,即转化生长因子-α(TGF-α);肝素结合表皮生长因子样生长因子(HB-EGF);以及双调蛋白,当外源性给予这些配体时,它们增加了NHBECs中PGE2的释放。中和双调蛋白功能的浓度的肝素或抗TGFα或HB-EGF的抗体也减少了IFN-γ刺激的NHBECs中PGE2的释放。这些数据与存在自分泌生长因子/EGF受体环调节支气管上皮细胞中PGHS-2表达和PGE2合成一致。